In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 3rd, 2005 | 30 | Yes |
Popular Name: PODOPHYLLOTOXIN PODOPHYLLOTOXIN
Find On: PubMed — Wikipedia — Google
CAS Numbers: 4354-76-1 , 518-28-5 , [518-28-5]
(-)-Podophyllotoxin [518-28-5]
(-)-podophyllotoxin; PPT; Podofilox; Podophyllinic acid lactone
(-)-PODOPHYLLOTOXIN; [518-28-5]
518-28-5; C10874; Podophyllotoxin
518-28-5; Condylox (TN); D05529; Podofilox (USAN); Podophyllotoxin (BAN)
518-28-5; Podophyllotoxin; Prestwick_1018
CPD000059121; Podofilox; Podophyllotoxin; SAM002548978
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.32 | 4.95 | -16.81 | 1 | 8 | 0 | 93 | 414.41 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.14e-01 g/l | DrugBank-approved |
MP | 140-165o C | Indofine |
Mp [°C] | 178 - 184 | Acros Organics |
MP | 182 - 184 | Enamine Building Blocks |
MP | 182...184 | Enamine Building Blocks |
MP | 183 - 184 | Enamine Building Blocks |
MP | 183-184 °C(lit.) | Indofine |
MP | 183...184 | Enamine Building Blocks |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 97% | APIChem |
UniProt Database Links | ADPPT_HUMAN; ADPPT_MOUSE; ADPPT_PONAB; ADPPT_RAT; ADPPT_XENLA; DEF_PETIN; FAS2_YEAST; GLNA1_ALNGL; GLNA1_CHLRE; GLNA1_MEDSA; GLNA1_PEA; GLNA1_PHAVU; GLNA1_SOYBN; GLNA2_MEDSA; GLNA2_PEA; GLNA2_PHAVU; GLNA3_PEA; GLNA3_PHAVU; GLNA4_PEA; GLNA4_PHAVU; GLNA_LAC | ChEBI |
Therapy | antineoplastic, inhibits microtubule assembly, and human DNA topoisomerase II; antimitotic agent | SMDC Iconix |
Indications | antiviral, Genital Warts | KeyOrganics Bioactives |
mechanism | Cell division inhibitor | IBScreen Bioactives IBScreen Bioactives |
biological_use | Cytostatic | IBScreen Bioactives |
Patent Database Links | EP1520588; EP1724350; EP1872775; EP1958961; US2001020038; US2004054186; US2004073026; US2005049263; US2005064563; US2005137207; US2005256183; US2005267175; US2006024317; US2006079563; US2006106065; US2007189977; US2007196323; US2007196325; US2007196453; U | ChEBI |
H phrase | H310: Fatal in contact with skin | Acros Organics |
H phrase | H310: Fatal in contact with skin; H301: Toxic if swallowed; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation | Acros Organics |
mechanism | Inhibitor of human DNA topoisomerase II | IBScreen Bioactives |
biological_source | Isol. from Podophyllum emodi, Diphylleia grayi and others | ZereneX Building Blocks |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Enamine; NCC_SUPPLIER_STRUCTURE_ID : 207702035 | NIH Clinical Collection via PubChem |
P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician | Acros Organics |
P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician; P280: Wear protective gloves/protective clothing/eye protection/face protection; P312: Call a POISON CENTER or doctor/physician if you feel unwell; P302 + P350: IF ON SKIN: G | Acros Organics |
R phrase | R23/25: Toxic by inhalation and if swallowed. | Acros Organics |
R phrase | R23/25: Toxic by inhalation and if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin. | Acros Organics |
mechanism | Reported to bind to tubulin | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Enamine; SUPPLIER_STRUCTURE_ID: 207702035 | NIH Clinical Collection via PubChem |
SOLUBILITY | Soluble in Methylene chloride/methanol | Indofine |
Hazard | T: Toxic | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GCR-1-E | Glucocorticoid Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 14 | 0.37 | Binding ≤ 10μM |
O46399-1-E | Beta Tubulin (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.26 | Binding ≤ 10μM |
Q862F3-2-E | Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2500 | 0.26 | Binding ≤ 10μM |
Q862L2-2-E | Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic | Eukaryotes | 2500 | 0.26 | Binding ≤ 10μM |
Q9MZB0-1-E | Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3000 | 0.26 | Binding ≤ 10μM |
TBA1A-1-E | Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2180 | 0.26 | Binding ≤ 10μM |
TBA4A-1-E | Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.27 | Binding ≤ 10μM |
TBB-1-E | Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1560 | 0.27 | Binding ≤ 10μM |
TBB1-1-E | Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 460 | 0.30 | Binding ≤ 10μM |
TBB2B-1-E | Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.26 | Binding ≤ 10μM |
TBB3-1-E | Tubulin Beta-3 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2180 | 0.26 | Binding ≤ 10μM |
TBB4A-1-E | Tubulin Beta-4 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.25 | Binding ≤ 10μM |
TBB4B-1-E | Tubulin Beta-2 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.25 | Binding ≤ 10μM |
TBB5-1-E | Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.25 | Binding ≤ 10μM |
TBB8-1-E | Tubulin Beta-8 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.25 | Binding ≤ 10μM |
TBG1-1-E | Tubulin Gamma-1 Chain (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2180 | 0.26 | Binding ≤ 10μM |
Q862F3-1-E | Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 590 | 0.29 | Functional ≤ 10μM |
Q862L2-1-E | Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 590 | 0.29 | Functional ≤ 10μM |
TBA1A-1-E | Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 460 | 0.30 | Functional ≤ 10μM |
TBB1-1-E | Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 460 | 0.30 | Functional ≤ 10μM |
TBB2B-1-E | Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic | Eukaryotes | 590 | 0.29 | Functional ≤ 10μM |
Z100695-1-O | WRL68 (Embryonic Hepatoma Cells) (cluster #1 Of 1), Other | Other | 4800 | 0.25 | Functional ≤ 10μM |
Z101973-1-O | Paracentrotus Lividus (cluster #1 Of 1), Other | Other | 500 | 0.29 | Functional ≤ 10μM |
Z50425-1-O | Plasmodium Falciparum (cluster #1 Of 22), Other | Other | 10000 | 0.23 | Functional ≤ 10μM |
Z50426-3-O | Plasmodium Falciparum (isolate K1 / Thailand) (cluster #3 Of 9), Other | Other | 12 | 0.37 | Functional ≤ 10μM |
Z50602-2-O | Human Herpesvirus 1 (cluster #2 Of 5), Other | Other | 50 | 0.34 | Functional ≤ 10μM |
Z50607-1-O | Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other | Other | 3 | 0.40 | Functional ≤ 10μM |
Z50651-2-O | Vesicular Stomatitis Virus (cluster #2 Of 2), Other | Other | 100 | 0.33 | Functional ≤ 10μM |
Z80002-1-O | 1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other | Other | 3 | 0.40 | Functional ≤ 10μM |
Z80054-1-O | Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other | Other | 500 | 0.29 | Functional ≤ 10μM |
Z80110-1-O | CV-1 (Kidney Cells) (cluster #1 Of 2), Other | Other | 29 | 0.35 | Functional ≤ 10μM |
Z80121-1-O | DMS-79 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other | Other | 23 | 0.36 | Functional ≤ 10μM |
Z80125-1-O | DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other | Other | 52 | 0.34 | Functional ≤ 10μM |
Z80156-1-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other | Other | 2750 | 0.26 | Functional ≤ 10μM |
Z80164-1-O | HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other | Other | 8100 | 0.24 | Functional ≤ 10μM |
Z80166-1-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other | Other | 50 | 0.34 | Functional ≤ 10μM |
Z80186-6-O | K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other | Other | 30 | 0.35 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 8500 | 0.24 | Functional ≤ 10μM |
Z80284-3-O | MOLT-3 (T-lymphoblastic Leukemia Cells) (cluster #3 Of 3), Other | Other | 14 | 0.37 | Functional ≤ 10μM |
Z80354-4-O | OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other | Other | 460 | 0.30 | Functional ≤ 10μM |
Z80362-1-O | P388 (Lymphoma Cells) (cluster #1 Of 8), Other | Other | 50 | 0.34 | Functional ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 13 | 0.37 | Functional ≤ 10μM |
Z80414-1-O | Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other | Other | 18 | 0.36 | Functional ≤ 10μM |
Z80427-1-O | RKO (Colon Carcinoma) (cluster #1 Of 1), Other | Other | 29 | 0.35 | Functional ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 7630 | 0.24 | Functional ≤ 10μM |
Z80697-1-O | Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other | Other | 9 | 0.38 | Functional ≤ 10μM |
Z80819-1-O | J774.2 (cluster #1 Of 1), Other | Other | 13 | 0.37 | Functional ≤ 10μM |
Z80847-1-O | FaDu (Pharyngeal Carcinoma Cells) (cluster #1 Of 3), Other | Other | 7 | 0.38 | Functional ≤ 10μM |
Z80866-1-O | GLC4 Cell Line (cluster #1 Of 1), Other | Other | 60 | 0.34 | Functional ≤ 10μM |
Z80874-1-O | CEM (T-cell Leukemia) (cluster #1 Of 7), Other | Other | 7 | 0.38 | Functional ≤ 10μM |
Z80936-1-O | HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other | Other | 17 | 0.36 | Functional ≤ 10μM |
Z81020-3-O | HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other | Other | 500 | 0.29 | Functional ≤ 10μM |
Z81115-1-O | KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other | Other | 8 | 0.38 | Functional ≤ 10μM |
Z81135-1-O | L6 (Skeletal Muscle Myoblast Cells) (cluster #1 Of 4), Other | Other | 150 | 0.32 | Functional ≤ 10μM |
Z81244-1-O | J774 (Macrophage Cells) (cluster #1 Of 1), Other | Other | 16 | 0.36 | Functional ≤ 10μM |
Z81247-2-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other | Other | 69 | 0.33 | Functional ≤ 10μM |
Z81252-3-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other | Other | 8 | 0.38 | Functional ≤ 10μM |
Z81335-2-O | HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other | Other | 1000 | 0.28 | Functional ≤ 10μM |
Z80052-1-O | C8166 (Leukemic T-cells) (cluster #1 Of 1), Other | Other | 150 | 0.32 | ADME/T ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other | Other | 34 | 0.35 | ADME/T ≤ 10μM |
Z80583-1-O | Vero (Kidney Cells) (cluster #1 Of 3), Other | Other | 23 | 0.36 | ADME/T ≤ 10μM |
Z81115-2-O | KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other | Other | 5 | 0.39 | ADME/T ≤ 10μM |
Z81135-3-O | L6 (Skeletal Muscle Myoblast Cells) (cluster #3 Of 6), Other | Other | 9 | 0.38 | ADME/T ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 1), Other | Other | 31 | 0.35 | ADME/T ≤ 10μM |
VE2-1-V | Human Papillomavirus Regulatory Protein E2 (cluster #1 Of 1), Viral | Viruses | 1050 | 0.28 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 14 | 0.37 | Binding ≤ 1μM |
TBA1A_PIG | P02550 | Tubulin Alpha Chain, Pig | 460 | 0.30 | Binding ≤ 1μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 460 | 0.30 | Binding ≤ 1μM |
TBB1_HUMAN | Q9H4B7 | Tubulin Beta-1 Chain, Human | 1000 | 0.28 | Binding ≤ 1μM |
TBB4B_HUMAN | P68371 | Tubulin Beta-2 Chain, Human | 1000 | 0.28 | Binding ≤ 1μM |
TBB3_HUMAN | Q13509 | Tubulin Beta-3 Chain, Human | 1000 | 0.28 | Binding ≤ 1μM |
TBB4A_HUMAN | P04350 | Tubulin Beta-4 Chain, Human | 1000 | 0.28 | Binding ≤ 1μM |
TBB8_HUMAN | Q3ZCM7 | Tubulin Beta-8 Chain, Human | 1000 | 0.28 | Binding ≤ 1μM |
O46399_SHEEP | O46399 | Beta Tubulin, Sheep | 3000 | 0.26 | Binding ≤ 10μM |
GCR_HUMAN | P04150 | Glucocorticoid Receptor, Human | 14 | 0.37 | Binding ≤ 10μM |
VE2_HPV1A | P03118 | Regulatory Protein E2, Hpv1a | 1050 | 0.28 | Binding ≤ 10μM |
Q862F3_BOVIN | Q862F3 | Tubulin Alpha Chain, Bovin | 1700 | 0.27 | Binding ≤ 10μM |
TBA1A_PIG | P02550 | Tubulin Alpha Chain, Pig | 1560 | 0.27 | Binding ≤ 10μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 460 | 0.30 | Binding ≤ 10μM |
Q862L2_BOVIN | Q862L2 | Tubulin Alpha-1 Chain, Bovin | 1700 | 0.27 | Binding ≤ 10μM |
TBA4A_HUMAN | P68366 | Tubulin Alpha-1 Chain, Human | 1700 | 0.27 | Binding ≤ 10μM |
Q9MZB0_SHEEP | Q9MZB0 | Tubulin Alpha-1 Chain, Sheep | 3000 | 0.26 | Binding ≤ 10μM |
TBA1A_HUMAN | Q71U36 | Tubulin Alpha-3 Chain, Human | 2180 | 0.26 | Binding ≤ 10μM |
TBB2B_BOVIN | Q6B856 | Tubulin Beta Chain, Bovin | 1700 | 0.27 | Binding ≤ 10μM |
TBB_PIG | P02554 | Tubulin Beta Chain, Pig | 1560 | 0.27 | Binding ≤ 10μM |
TBB2B_RAT | Q3KRE8 | Tubulin Beta Chain, Rat | 2180 | 0.26 | Binding ≤ 10μM |
TBB1_HUMAN | Q9H4B7 | Tubulin Beta-1 Chain, Human | 1000 | 0.28 | Binding ≤ 10μM |
TBB4B_HUMAN | P68371 | Tubulin Beta-2 Chain, Human | 1000 | 0.28 | Binding ≤ 10μM |
TBB3_RAT | Q4QRB4 | Tubulin Beta-3 Chain, Rat | 2180 | 0.26 | Binding ≤ 10μM |
TBB3_HUMAN | Q13509 | Tubulin Beta-3 Chain, Human | 1000 | 0.28 | Binding ≤ 10μM |
TBB4A_HUMAN | P04350 | Tubulin Beta-4 Chain, Human | 1000 | 0.28 | Binding ≤ 10μM |
TBB5_HUMAN | P07437 | Tubulin Beta-5 Chain, Human | 2180 | 0.26 | Binding ≤ 10μM |
TBB8_HUMAN | Q3ZCM7 | Tubulin Beta-8 Chain, Human | 1000 | 0.28 | Binding ≤ 10μM |
TBG1_RAT | P83888 | Tubulin Gamma-1 Chain, Rat | 2180 | 0.26 | Binding ≤ 10μM |
Z80002 | Z80002 | 1A9 (Ovarian Adenocarcinoma Cells) | 3 | 0.40 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 12 | 0.37 | Functional ≤ 10μM |
Z80697 | Z80697 | Bel-7402 (Hepatoma Cells) | 9.1 | 0.38 | Functional ≤ 10μM |
Z80054 | Z80054 | Caco-2 (Colon Adenocarcinoma Cells) | 500 | 0.29 | Functional ≤ 10μM |
Z80874 | Z80874 | CEM (T-cell Leukemia) | 7.2 | 0.38 | Functional ≤ 10μM |
Z80110 | Z80110 | CV-1 (Kidney Cells) | 29 | 0.35 | Functional ≤ 10μM |
Z80121 | Z80121 | DMS-79 (Small Cell Lung Carcinoma Cells) | 23 | 0.36 | Functional ≤ 10μM |
Z80125 | Z80125 | DU-145 (Prostate Carcinoma) | 2970 | 0.26 | Functional ≤ 10μM |
Z80847 | Z80847 | FaDu (Pharyngeal Carcinoma Cells) | 7.2 | 0.38 | Functional ≤ 10μM |
Z80866 | Z80866 | GLC4 Cell Line | 150 | 0.32 | Functional ≤ 10μM |
Z81335 | Z81335 | HCT-15 (Colon Adenocarcinoma Cells) | 1000 | 0.28 | Functional ≤ 10μM |
Z80936 | Z80936 | HEK293 (Embryonic Kidney Fibroblasts) | 17 | 0.36 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 100 | 0.33 | Functional ≤ 10μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 24 | 0.36 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 2750 | 0.26 | Functional ≤ 10μM |
Z80164 | Z80164 | HT-1080 (Fibrosarcoma Cells) | 8100 | 0.24 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 11 | 0.37 | Functional ≤ 10μM |
Z50602 | Z50602 | Human Herpesvirus 1 | 50 | 0.34 | Functional ≤ 10μM |
Z50607 | Z50607 | Human Immunodeficiency Virus 1 | 2.9 | 0.40 | Functional ≤ 10μM |
Z81244 | Z81244 | J774 (Macrophage Cells) | 16.4 | 0.36 | Functional ≤ 10μM |
Z80819 | Z80819 | J774.2 | 11.3 | 0.37 | Functional ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 30 | 0.35 | Functional ≤ 10μM |
Z81115 | Z81115 | KB (Squamous Cell Carcinoma) | 0.5 | 0.43 | Functional ≤ 10μM |
Z81135 | Z81135 | L6 (Skeletal Muscle Myoblast Cells) | 12 | 0.37 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 15 | 0.37 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 26 | 0.35 | Functional ≤ 10μM |
Z80284 | Z80284 | MOLT-3 (T-lymphoblastic Leukemia Cells) | 14 | 0.37 | Functional ≤ 10μM |
Z80354 | Z80354 | OVCAR-3 (Ovarian Adenocarcinoma Cells) | 460 | 0.30 | Functional ≤ 10μM |
Z80362 | Z80362 | P388 (Lymphoma Cells) | 12 | 0.37 | Functional ≤ 10μM |
Z101973 | Z101973 | Paracentrotus Lividus | 20 | 0.36 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 10 | 0.37 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.23 | Functional ≤ 10μM |
Z50426 | Z50426 | Plasmodium Falciparum (isolate K1 / Thailand) | 12 | 0.37 | Functional ≤ 10μM |
Z80414 | Z80414 | Raji (B-lymphoblastic Cells) | 18 | 0.36 | Functional ≤ 10μM |
Z80427 | Z80427 | RKO (Colon Carcinoma) | 29 | 0.35 | Functional ≤ 10μM |
Q862F3_BOVIN | Q862F3 | Tubulin Alpha Chain, Bovin | 1200 | 0.28 | Functional ≤ 10μM |
TBA1A_RAT | P68370 | Tubulin Alpha-1 Chain, Rat | 350 | 0.30 | Functional ≤ 10μM |
Q862L2_BOVIN | Q862L2 | Tubulin Alpha-1 Chain, Bovin | 1200 | 0.28 | Functional ≤ 10μM |
TBB2B_BOVIN | Q6B856 | Tubulin Beta Chain, Bovin | 1200 | 0.28 | Functional ≤ 10μM |
TBB1_HUMAN | Q9H4B7 | Tubulin Beta-1 Chain, Human | 350 | 0.30 | Functional ≤ 10μM |
Z50651 | Z50651 | Vesicular Stomatitis Virus | 100 | 0.33 | Functional ≤ 10μM |
Z100695 | Z100695 | WRL68 (Embryonic Hepatoma Cells) | 4800 | 0.25 | Functional ≤ 10μM |
Z80052 | Z80052 | C8166 (Leukemic T-cells) | 150 | 0.32 | ADME/T ≤ 10μM |
Z81115 | Z81115 | KB (Squamous Cell Carcinoma) | 3 | 0.40 | ADME/T ≤ 10μM |
Z81135 | Z81135 | L6 (Skeletal Muscle Myoblast Cells) | 10 | 0.37 | ADME/T ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 31 | 0.35 | ADME/T ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 12.5 | 0.37 | ADME/T ≤ 10μM |
Z80583 | Z80583 | Vero (Kidney Cells) | 16 | 0.36 | ADME/T ≤ 10μM |
Description | Species |
---|---|
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Formation of tubulin folding intermediates by CCT/TriC | |
Gap junction assembly | |
Kinesins | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MHC class II antigen presentation | |
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | |
Mitotic Prometaphase | |
Platelet degranulation | |
Post-chaperonin tubulin folding pathway | |
Prefoldin mediated transfer of substrate to CCT/TriC | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
Separation of Sister Chromatids | |
Translocation of GLUT4 to the plasma membrane |